Brief: Pulmatrix Announces Positive Top-Line Data Evaluating PUR1800 In Patients With Stable COPD
21/03/2022 13:43
March 21 (Reuters) - Pulmatrix Inc PULM.O :
* PULMATRIX ANNOUNCES POSITIVE TOP-LINE DATA EVALUATING
PUR1800 IN
PATIENTS WITH STABLE COPD
* PULMATRIX INC - PUR1800 WAS WELL-TOLERATED AND THERE WERE
NO
OBSERVED SAFETY SIGNALS IN STUDY
Source text for Eikon: ID:nPn5k7Q00a
Further company coverage: PULM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulmatrix
See all newsBrief: Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger
Pulmatrix Q2 loss narrows on clinical development hold
Pulmatrix Q1 net loss narrows, clinical development on hold
Brief: Pulmatrix Announces Closing Of Preferred Stock Transaction As Part Of Planned Merger
NASDAQ RESUMED AT 09:00 AM